IMMX vs TFX · $640.7M cap vs P/E 2083, rev $1.12B
Immix Biopharma Inc (IMMX) versus Teleflex Incorporated (TFX) — a side-by-side from cached financials, not a winner call.
Immix Biopharma Inc (IMMX) is a biotechnology company listed on US.
Teleflex Incorporated (TFX) is a medical instruments & supplies company listed on NYSE.
IMMX does not have a complete income-statement cache yet.
Latest reported TFX revenue for 2026-06-30 was $1.12B. Net income was $91.5M. TFX currently screens at market cap $5.53B and trailing P/E 2082.7.
IMMX currently screens at market cap $640.7M. TFX currently screens at market cap $5.53B and trailing P/E 2082.7.
Not investment advice. Open the IMMX and TFX stock pages for the full models.
Not investment advice.